Live tape
Top 8, mentions 7d8,858GOOGL1,691 mentions▲ +0.04MRNA1,354 mentions▲ +0.09SNDK1,285 mentions▲ +0.11META1,126 mentions▲ +0.03NVDA1,045 mentions▲ +0.08SPCX899 mentions▲ +0.08NBIS744 mentions▲ +0.09MSFT714 mentions▲ +0.05

Equity · Healthcare

VTRS

Viatris Inc. · NasdaqGS

$17.30 −0.06% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart
Our own end-of-day closes 38 sessions
$18 $15 22 May 17 Jul

The line runs $16.64 on 22 May through $17.30 on 17 July, on a scale from $15 to $18. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of VTRS over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 38 sessions over that window: $16.64 on 22 May 2026 through $17.30 on 17 July 2026.

Market cap $19.9B
52-week range $8.75 – $17.38
Avg volume 3.0M

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 19, 2026

VTRS insider trades

SEC Form 4 · last 90 days · newest reported trade 25 Jun 2026
Open-market buys 0
Open-market sells 1
Net sold $810K
Non-trade filings 2
Date Insider Type Shares Value
25 Jun 2026 Campbell Paul See Remarks Sell 50,076 $810K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
15 Aug 2026 Enrietti Andrew See Remarks Option exercise 26,133
15 Aug 2026 Enrietti Andrew See Remarks Tax withheld 11,366 $184K

VTRS reported financials

SEC EDGAR XBRL

VTRS reported revenue of $14.3B for the fiscal year ended 31 Dec 2025. Net income over the same period was −$3.5B.

Figure Reported Period
Revenue $14.3B 31 Dec 2025 fiscal year
Net income −$3.5B 31 Dec 2025 fiscal year
Diluted EPS −$3.00 31 Dec 2025 fiscal year
Total assets $35.0B 30 Jun 2026 at period end
Total equity incl. minority interest $14.3B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

VTRS earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-0.10 $3.76B
31 Mar 2026 Q1 2026 $0.15 $3.52B
31 Dec 2025 FY 2025 $-3.00 $14.30B
30 Sep 2025 Q3 2025 $-0.11 $3.76B
30 Jun 2025 Q2 2025 $0.00 $3.58B
31 Mar 2025 Q1 2025 $-2.55 $3.25B
31 Dec 2024 FY 2024 $-0.53 $14.74B
30 Sep 2024 Q3 2024 $0.08 $3.75B

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

VTRS institutional holders

SEC Form 13F

12 of the 45 institutional funds we track reported a VTRS position for the quarter ended 30 Jun 2026 — a combined $369.2M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Glenview Capital Management Held (±25%) +8.7% shares 9,877,409 $156.9M
AQR Capital Management Trimmed −26.0% shares 4,694,966 $74.6M
Man Group Held (±25%) −13.9% shares 3,523,052 $55.9M
Bridgewater Associates Added +134.0% shares 1,698,341 $27.0M
Marshall Wace Trimmed −91.0% shares 839,820 $13.3M
D. E. Shaw & Co. Trimmed −79.6% shares 791,371 $12.6M
Point72 Asset Management Trimmed −68.3% shares 563,129 $8.9M
Citadel Advisors Trimmed −87.4% shares 502,259 $8.0M
Millennium Management Trimmed −88.6% shares 314,043 $5.0M
Two Sigma Investments Held (±25%) +18.6% shares 238,000 $3.8M

Showing the 10 largest of 12 reported positions. The figures above count all of them.

Source: SEC EDGAR 13F filings

VTRS fails-to-deliver

SEC CNS data

On 29 Jul 2026, 50 shares of VTRS failed to deliver (about $893).

Settlement date Shares failed Notional % of shares out
29 Jul 2026 50 $893 <0.001%
23 Jul 2026 86,292 $1.5M 0.008%
22 Jul 2026 6,805 $120K 0.001%
20 Jul 2026 36,289 $627K 0.003%
17 Jul 2026 621 $11K <0.001%
15 Jul 2026 6,505 $106K 0.001%
09 Jul 2026 338 $6K <0.001%
07 Jul 2026 480 $8K <0.001%
06 Jul 2026 468 $8K <0.001%

Source: SEC fails-to-deliver (CNS) data